Emergent BioSolutions Inc (EBS)

32.85
NYSE : Health Care
Prev Close 32.85
Day Low/High 0.00 / 0.00
52 Wk Low/High 27.01 / 44.38
Avg Volume 760.80K
Exchange NYSE
Shares Outstanding 40.06M
Market Cap 1.35B
EPS 1.60
P/E Ratio 14.69
Div & Yield N.A. (N.A)

Latest News

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Emergent BioSolutions, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Emergent BioSolutions, Inc.

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Emergent BioSolutions, Inc.

EBS March 2017 Options Begin Trading

EBS March 2017 Options Begin Trading

Investors in Emergent BioSolutions Inc saw new options begin trading today, for the March 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

SHAREHOLDER ALERT: Investigation Of Emergent Biosolutions, Inc. Announced By Holzer & Holzer, LLC

SHAREHOLDER ALERT: Investigation Of Emergent Biosolutions, Inc. Announced By Holzer & Holzer, LLC

Holzer & Holzer, LLC is investigating whether certain statements made by Emergent Biosolutions, Inc.

Emergent BioSolutions (EBS) Highlighted As Weak On High Volume

Emergent BioSolutions (EBS) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Emergent BioSolutions (EBS) as a weak on high relative volume candidate

New Lifetime High For Emergent BioSolutions (EBS)

New Lifetime High For Emergent BioSolutions (EBS)

Trade-Ideas LLC identified Emergent BioSolutions (EBS) as a new lifetime high candidate

New Lifetime High Reached By Emergent BioSolutions (EBS)

New Lifetime High Reached By Emergent BioSolutions (EBS)

Trade-Ideas LLC identified Emergent BioSolutions (EBS) as a new lifetime high candidate

New Lifetime High Reached: Emergent BioSolutions (EBS)

New Lifetime High Reached: Emergent BioSolutions (EBS)

Trade-Ideas LLC identified Emergent BioSolutions (EBS) as a new lifetime high candidate

Banks Hold Steady After Fed Minutes

At the opening bell, banks took off prior to the release of the Fed minutes and managed to maintain their ground afterwards.

Trade-Ideas: Emergent BioSolutions (EBS) Is Today's New Lifetime High Stock

Trade-Ideas: Emergent BioSolutions (EBS) Is Today's New Lifetime High Stock

Trade-Ideas LLC identified Emergent BioSolutions (EBS) as a new lifetime high candidate